Andhra University Transferred Patented Technology for Commercialisation to Industry for the first time
Vishakhapatnam: Andhra University and Akshaya Innotech, signed a the technology transfer licensing agreement for the transfer of patented technology on“Portable novel biosensor for type 2 diabetes” today in the presence of all the Principals, HODs , Deans and many senior officials of the university and the Company.
During the Technology Licensing agreement signing ceremony the Hon’ble Vice Chancellor, Prof PVGD Prasad Reddy expressed his happiness and said it is a historic day in the annals of Andhra University as the University has successfully transferred a novel technology for the first time to a Start-up for commercialisation. The technology licensing agreement was signed by Prof V Krishna Mohan Registrar and Dr V, R Sarath Babu Technical Head and Partner on behalf of the University and the Company respectively.
Prof H Purushotham DPIIT-IPR Chair Professor who spotted the entrepreneur and coordinated the transfer of the technology and Dr Aparanji the faculty member who developed the technology said it is a novel biosensor device using SPR powered technology with novel diabetes biomarker GLP1 peptide.
The strip-free device is environment friendly economical and sustainable, as it can be reused by multiple patients for multiple times. The biosensor device has wide range of applications, it can be used for wide applications such as studying enzyme kinetics, drug interactions, active site and precipitation reactions, DNA hybridizations, and also in cancer diagnosis and has huge market potential.
The distinction of the technology is strip free which can detect and predict diabetes of type 2 and diabetes in insulin insensitive patients. The biosensor device is of high specificity, gives accurate results and is compatible with android, windows and iOS.
The process will help Akshaya Innotech to start indigenous production of the biosensor as a part of its ‘Make in India’. Akshaya Innotech has a strong team of professionals. The core team is assisted by an R&D team with a cumulative experience of more than twenty years of experience.